WANG Ze-lan,SHEN Tian-ran,LI Zhen,LING Wen-hua.. Diagnosis value of serum interleukin-33 for non-alcoholic fatty liver disease[J].S China J Prev Med, 2014, 40(2): 101-104.
[1]Moore JB.Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome[J].Proc Nutr Soc,2010,69(2):211-220. [2]Yang Z,Liang Y,Xi W,et al. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population[J].Clin Exp Med,2011,11(2):75-80. [3]Miyagaki T,Sugaya M,Yokobayashi H,et al. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection[J].J Invest Dermatol,2011,131(3):794-796. [4]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中国肝脏病杂志,2010,2( 4):43-48. [5]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161. [6]邱强,陈香美,谢院生.影响IgA 肾病高尿酸血症的因素[J].中国中西医结合肾病杂志,2005,6(6):329-331. [7]Schmitz J,Owyang A,Oldham E,et al. IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J].Immunity,2005,23(5):479-490. [8]Arshad MI,Rauch M,Lhelgoualch A,et al. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis[J].Eur J Immunol,2011,41(8):2341-2348. [9]Wang J,Zhao P,Guo H,et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C[EB/OL].[2012-02-24].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270460/. [10]Miller AM.Role of IL-33 in in ammation and disease[J].J Inflamm (Lond),2011,8(1):22-34. [11]Baynes RD,Cook JD,Bothwell TH,et al. Serum transferrin receptors in hereditary hemochromatosis and African siderosis[J].Am J Hematol,1994,45(4):288-292. [12]Chiang PH,Chang TY,Chen JD.Synergistic effect of fatty liver and smoking on metabolic syndrome[J].World J Gastroenterol, 2009,15( 42):5334 -5339.